Korro Bio Inc
NASDAQ:KRRO
Korro Bio Inc
NASDAQ:KRRO
Price:
13.08
USD
-2.82%
Market Closed
Market Cap:
$188.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Korro Bio Inc
NASDAQ:KRRO
|
US |
|
R
|
Raydium Semiconductor Corp
TWSE:3592
|
TW |
|
BlueScope Steel Ltd
ASX:BSL
|
AU |
|
Salvatore Ferragamo SpA
MIL:SFER
|
IT |
|
Avacta Group PLC
LSE:AVCT
|
UK |
|
Arcimoto Inc
OTC:FUVV
|
US |
|
Medcom Tech SA
MAD:MED
|
ES |
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
AU |
|
Qorvo Inc
NASDAQ:QRVO
|
US |
|
Kairos Minerals Ltd
ASX:KAI
|
AU |
|
PubMatic Inc
NASDAQ:PUBM
|
US |
|
Angel Seafood Holdings Ltd
ASX:AS1
|
AU |
|
Ceridian HCM Holding Inc
NYSE:DAY
|
US |
|
M
|
Multitrend Indo Tbk PT
IDX:BABY
|
ID |
|
A
|
AllDay Marts Inc
XPHS:ALLDY
|
PH |
|
I
|
Inmobiliaria Park Rose Iberoamericana SOCIMI SA
MAD:YPARK
|
ES |
|
Info Edge (India) Ltd
NSE:NAUKRI
|
IN |
|
Everyman Media Group PLC
LSE:EMAN
|
UK |
|
R
|
Rewardle Holdings Ltd
ASX:RXH
|
AU |
Balance Sheet
Balance Sheet Decomposition
Korro Bio Inc
Korro Bio Inc
Balance Sheet Decomposition is not available for
Korro Bio Inc
Korro Bio Inc
Balance Sheet
Korro Bio Inc
Korro Bio Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
18
|
42
|
200
|
220
|
80
|
52
|
166
|
56
|
22
|
|
| Cash Equivalents |
18
|
42
|
200
|
220
|
80
|
52
|
166
|
56
|
22
|
|
| Short-Term Investments |
0
|
0
|
17
|
0
|
35
|
19
|
0
|
70
|
53
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Accounts Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
3
|
4
|
1
|
2
|
7
|
4
|
6
|
|
| Total Current Assets |
18
|
43
|
221
|
225
|
120
|
57
|
173
|
132
|
82
|
|
| PP&E Net |
2
|
2
|
2
|
38
|
6
|
12
|
43
|
52
|
16
|
|
| PP&E Gross |
2
|
2
|
2
|
38
|
6
|
12
|
43
|
52
|
16
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
3
|
2
|
4
|
8
|
7
|
11
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
12
|
0
|
0
|
37
|
10
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
2
|
1
|
5
|
6
|
6
|
5
|
|
| Total Assets |
20
N/A
|
45
+125%
|
223
+402%
|
265
+19%
|
128
-52%
|
74
-42%
|
222
+201%
|
226
+2%
|
114
-50%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
2
|
1
|
6
|
1
|
3
|
7
|
4
|
2
|
|
| Accrued Liabilities |
1
|
2
|
3
|
7
|
0
|
6
|
11
|
7
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
10
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
48
|
14
|
4
|
0
|
1
|
4
|
0
|
|
| Total Current Liabilities |
2
|
4
|
53
|
27
|
5
|
9
|
19
|
15
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
15
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
3
|
31
|
1
|
0
|
32
|
51
|
50
|
|
| Total Liabilities |
3
N/A
|
8
+193%
|
56
+608%
|
72
+29%
|
6
-92%
|
9
+51%
|
52
+481%
|
66
+27%
|
62
-6%
|
|
| Equity | ||||||||||
| Common Stock |
47
|
85
|
0
|
0
|
164
|
164
|
0
|
0
|
0
|
|
| Retained Earnings |
30
|
49
|
69
|
95
|
44
|
102
|
183
|
267
|
384
|
|
| Additional Paid In Capital |
0
|
1
|
236
|
288
|
2
|
3
|
353
|
427
|
435
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
17
N/A
|
37
+115%
|
167
+356%
|
193
+15%
|
122
-37%
|
65
-47%
|
170
+162%
|
160
-6%
|
51
-68%
|
|
| Total Liabilities & Equity |
20
N/A
|
45
+125%
|
223
+402%
|
265
+19%
|
128
-52%
|
74
-42%
|
222
+201%
|
226
+2%
|
114
-50%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
31
|
31
|
31
|
34
|
8
|
8
|
8
|
9
|
9
|
|
Switch to:
Switch to:
See Also
Discover More
